banner

Module XVI D/E:
Advanced Cardiology
Sept. 28-30, 2018 - Nashville, TN

Register Now

Description

This advanced module will concentrate on cardiovascular disease, with a specific focus on the most recent clinical literature surrounding cardiovascular medicine breakthroughs. Expert faculty members will conduct didactic, instructional sessions, coupled with case presentations and patient studies. The entire curriculum for this module has been revised and updated, with both new topics and speakers. Sessions will be presented by lecturers in the following format:

  1. Cardiovascular Updates and Breakthrough Clinical Trials
  2. Clinical Didactic Presentation
  3. Clinical Case Presentations

Register

MODULE XVI D/E - Physician

$2,500.00
ADD TO CART

MODULE XVI D/E - Allied Health

$2,250.00
ADD TO CART

Learning Objectives

  • Discuss the Microbiome and Cardiovascular Disease (CVD)
  • Discuss Insulin Resistance, Metabolic Syndrome, Diabetes Mellitus, and CVD
  • Explain the Role of Heavy Metals and Toxins in CVD
  • Discuss Chelation Therapy for Heavy Metals and CVD
  • Discuss the Retina and Eye in CVD

Event Schedule

Friday, September 28, 2018

7:30 am

Cardiovasular Updates and Breakthroughs,Controversies in Cardiovascular Medicine and Clinical Trial Interpretation. The GI tract, Microbiome and Cardiovascular Disease with Clinical Case Presentations

Jill Carnahan MD, ABFM, ABIHM

9:30 am

Break

10:00 am

Cardiovasular Updates and Breakthroughs,Controversies in Cardiovascular Medicine and Clinical Trial Interpretation. Diabetes Mellitus, Insulin Resistance and Cardiovascular Disease with Clinical Case Presentations

Filomena Trindade MD, MPH

12:00 pm

Lunch

1:30 pm

Cardiovasular Updates and Breakthroughs,Controversies in Cardiovascular Medicine and Clinical Trial Interpretation. The Role of Heavy Metals in Hypertension, Dyslipidemia and Coronary Heart Disease, MI and Cardiovascular Disease with Clinical Case Presentations

Mark Houston MD, MS, MSc

3:30 pm

Break

4:00 pm

Cardiovasular Updates and Breakthroughs,Controversies in Cardiovascular Medicine and Clinical Trial Interpretation. The Role of Chelation Therapy in Cardiovascular Disease, Diabetes Mellitus and Heavy Metal Detoxification.
The TACT trials with Clinical Case Presentations

Jeanne Drisko MD

6:00 pm

Close of Session

Saturday, September 29, 2018

7:30 am

Cardiovasular Updates and Breakthroughs,Controversies in Cardiovascular Medicine and Clinical Trial Interpretation. Opthalmology and the Retina in Hypertension, Dyslipidemia, Cardiovascular Disease and Cerebrovascular Disease with Clinical Case Presentations

Shalesh Kaushal MD, PhD

9:30 am

Break

10:00 am

Cardiovasular Updates and Breakthroughs,Controversies in Cardiovascular Medicine and Clinical Trial Interpretation. Cerebrovascular Disease, Vascular Dementia, Carotid Artery Disease and Stroke. Diagnosis,Prevention and Treatment with Clinical Case Presentations

Fred Callahan MD

12:00 pm

Lunch

1:30 pm

Cardiovascular Risk Stratification with CV Scoring Systems, Lab testing and Non Invasive CV Testing with Clinical Cases

Mark Houston MD, MS, MSc

3:30 pm

Break

4:00 pm

Cardiovasular Updates and Breakthroughs,Controversies of Nutrition and Various Diets in Cardiovascular Disease: Ketogenic Diet, Paleolithic Diet, Fasting Mimicking Diet, Low Carbohydrate Diet and Other.

James LaValle RPh, CCN

6:00 pm

Close of Session

Sunday, September 30, 2018

7:00 am

The Role of CoEnzyme Q 10 in Cardiovascular Disease, Hypertension, Dyslipidemia and Congestive Heart Failure

Mark Houston MD, MS, MSc

8:00 am

Cardiovasular Updates and Breakthroughs,Controversies in Cardiovascular Medicine and Clinical Trial Interpretation. Part 1. Niacin and its Role in Dyslipidemia and Coronary Heart Disease

Mark Houston MD, MS, MSc

9:00 am

Break

9:30 am

Cardiovasular Updates and Breakthroughs,Controversies in Cardiovascular Medicine and Clinical Trial Interpretation. Part 2 Omega 3 Fatty Acids and their Role in Hypertension, Dyslipidemia, Coronary Heart Disease, MI and Cardiovascular Disease

Mark Houston MD, MS, MSc

11:30 am

Lunch

12:30 pm

Cardiovasular Updates and Breakthroughs,Controversies in Cardiovascular Medicine and Clinical Trial Interpretation. Part 3 Anti-Hypertensive Drug Therapy in Hypertension and Prevention of Cardiovascular Target Organ Damage and New AHA and ACC Guideline.

Mark Houston MD, MS, MSc

1:30 pm

The Role of Saturated Fatty Acids in Coronary Heart Disease and Myocardial Infarction Part 4

Mark Houston MD, MS, MSc

2:30 pm

Break

3:00 pm

Environmental Exposures and Autonomic Dysfunction

Andrew Heyman MD

5:00 pm

Close of Session


Register Today!

DYS
HRS
MIN
SEC

Accreditation

“This Activity is Jointy
Provided by Global
Education Group and A4M”

VIEW ACCREDITATION

Gaylord Opryland

2800 Opryland Drive
Nashville, TN 37214
Phone: 877-491-7397

Rm Rate: $219/night
Room Rate Expires: 9-7-18

September Event 2018

Save on your airfare by flying with Delta Airlines. Mention Code NMML7 and receive anywhere from a 3%-10% discount depending on class.

ADD EVENT TO MY CALENDAR 09/28/2018 07:30 AM 09/30/2018 06:00 PM America/New_York A4M Module XVI D/E Nashville, TN

Contact Us Today!

Contact Me About: